Pituitary adenylate cyclase-activating peptide: Difference between revisions
CSV import |
No edit summary Tag: Manual revert |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 30: | Line 30: | ||
{{protein-stub}} | {{protein-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Latest revision as of 18:42, 18 March 2025
Pituitary adenylate cyclase-activating peptide (PACAP) is a protein that in humans is encoded by the ADCYAP1 gene. It is a member of the secretin family of hormones and plays a critical role in the functioning of the central nervous system and the endocrine system.
Function[edit]
PACAP is a potent activator of adenylate cyclase, an enzyme involved in the production of cyclic AMP, a key messenger molecule in cells. It is involved in the regulation of numerous physiological processes, including neurotransmission, cell proliferation, and hormone secretion.
Structure[edit]
PACAP is a 38-amino acid peptide that shares significant structural similarities with other members of the secretin family, including vasoactive intestinal peptide (VIP) and growth hormone-releasing hormone (GHRH).
Clinical significance[edit]
Alterations in PACAP function have been implicated in a variety of diseases, including migraine, post-traumatic stress disorder (PTSD), and schizophrenia. It is also being investigated as a potential therapeutic target for these and other conditions.
See also[edit]
References[edit]
<references group="" responsive="1"></references>

